Radboud University Medical Center: Carcinoma trials
The registry lists 22 Carcinoma studies with Radboud University Medical Center as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 5Phase 2 7Phase 3 2No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal CarcinomatosisNot yet recruitingNCT06393543
- Phase II Dutasteride in Combination With CAB vs CAB in SDCRecruitingNCT05513365Phase 2
- Sentinel NOSE Study: Prospective Registration Study on the Sentinel Node Procedure for Bulky Squamous Cell Carcinoma of the Nasal Vestibule.CompletedNCT05637307Not applicable
- Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid CarcinomaCompletedNCT05507775Not applicable
- Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer PatientsCompletedNCT04291300Phase 2
- Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT ImagingStatus unknownNCT04222543Phase 2
- PSMA-PET Imaging Before and After ADT in Advanced SDC PatientsStatus unknownNCT04214353Not applicable
- Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck CarcinomaStatus unknownNCT03817307Not applicable
- Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal OriginStatus unknownNCT03699332Phase 1/2
- 89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSECompletedNCT03556046Phase 1
- Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma PatientsCompletedNCT03539406Phase 1
- Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal ChemotherapyCompletedNCT03364907
- PSMA-PET Imaging for Advanced ACC/SDCCompletedNCT03319641Not applicable
- Zirconium-89-girentuximab PET/CT Imaging in Renal Cell CarcinomaCompletedNCT02883153Phase 2/3
- Reflectance Confocal Microscopy in Basal Cell CarcinomaCompletedNCT02623101Not applicable
- Intraoperative Dual-modality Imaging in Renal Cell CarcinomaStatus unknownNCT02497599Phase 1
- IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)CompletedNCT02228954
- A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and NeckStatus unknownNCT02054442Phase 1/2
- Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal CancerCompletedNCT02002312Phase 2
- The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01227213
- Patient Selection for Hypoxia Modifying Treatments in Larynx CarcinomasCompletedNCT00160095
- Randomized Trial of ARCON in Larynx CancerCompletedNCT00147732Phase 3